It’s great to know that one of the strongest regulatory bodies in Nigeria have gotten a new head who is not only a veteran in the field but a very vibrant individual.
Professor Moji Christianah Adeyeye, wife of Senator Olusola Adeyeye (Osun Central) was recently appointed by President Buhari as the new Director-General of the National Agency for Food and Drug Administration and Control, NAFDAC.
Mrs. Adeyeye is the founder of Drugs for AIDS and HIV Patients, a nonprofit organization committed to prevention, education, care and treatment of HIV/AIDS children in Nigeria, takes over from Mr. Ademola Andrew Magbojuri who was appointed as the Acting Director-General of NAFDAC in September.
Professor Christianah’s Academic Profile
Professor Christianah attended the University of Nigeria, obtaining a BSc in pharmaceutics in 1976, and went on to the University of Georgia where she obtained an M.S and a Ph.D. in pharmaceutics in 1985 and 1988.
Her research interests include preformulation, early phase development of solid, semisolid and liquid dosage forms, and IND-based and intellectual property-driven late phase development or bench-to-bedside translational research.
Professor Christianah’s Career Profile
Professor Christianah is the Chief Executive Officer of Elim Pediatric Pharmaceuticals Inc.
She is the founding Chair of Biopharmaceutical Sciences and Professor of Pharmaceutics and Drug Product Evaluation at the College of Pharmacy, Roosevelt University in Schaumburg, Illinois.
Professor Christianah was Professor of Pharmaceutics and Manufacturing for 21 years at Duquesne University in Pittsburgh, PA. She is Senior Fulbright Scholar and Specialist and 2008 AAPS Fellow.

She has mentored over 15 PhD and M.S candidates. She has 5 patents, 55 peer-reviewed manuscripts, book chapters and books, and more than 140 scientific presentations.
She is the founder of a socially conscious start-up company; Elim Pediatric Pharmaceuticals. She uses her university lab for the early phase R&grin and partners with contract manufacturing organizations for the clinical and registration batches.